To investigate whether PI3K/AKT contributes to PRDX2-induced drug resistance in colon cancer, we used immunohistochemistry to detect PRDX2 and p-AKT protein levels in tumor tissues and their corresponding normal colorectal mucosal tissues from 50 colon cancer patients. Here, PRDX2 is linked to colonic neoplasm.